SpeakersAndrea RauResearch Director at the French National Institute for Research in Agriculture, Food, and the Environment (INRAE). Talk will be about data integration. Summary currently being written.
Etienne BechtResearcher at the Center for Inflammation Research (CRI). Talk will be about data deconvolution. Summary currently being written.
Fatima Al-ShahrourHead of the Bioinformatics Unit at Spanish National Cancer Research Centre (CNIO). Bioinformatics strategies to target cancer genomes considering inter and intratumor heterogeneityTumor heterogeneity presents significant obstacles in cancer treatment, often leading to treatment failure, drug resistance, and unfavorable patient outcomes. Precision oncology seeks to address these challenges by developing personalized treatment strategies through comprehensive data integration. Single-cell RNA-seq technology has the transformative capabilities to unravel tumor heterogeneity at transcriptional level. This technology enables the high-resolution characterization of cellular composition, dynamics, and the identification of distinct cancer cell subpopulations, biomarkers, drug resistance pathways, and therapeutic targets. However, the integration of scRNA-seq data and drug response profiles lacks robust computational methodologies. In this presentation, I will present the impact of tumor heterogeneity on treatment outcomes and discuss the available bioinformatics tools for personalized therapy selection. Specifically, I will introduce PanDrugs and Beyondcell tools as a solution to decipher tumor molecular alterations at bulk and single-cell level to facilitate personalized treatment selection and I will also present how we will apply these findings in the context of the cancer genomics projects. |
Online user: 2 | Privacy |